Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Magyar Onkologia|March 9, 2017
[The role of driver and subclonal mutations in pathogenesis of primary myelofibrosis]Réka Mózes, Ambrus Gángó, Zsófia Boha, et al.Orvosi Hetilap|April 11, 2018
[Multiplex ligation-dependent probe amplification in oncohematological diagnostics and research]Richárd Kiss, Szabolcs Kosztolányi, Ambrus Gángó, et al.Scientific Reports|September 17, 2021
Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significanceZsófia Kramer, István Kenessey, Ambrus Gángó, et al.Magyar Onkologia|March 9, 2017
[Molecular monitoring of myeloid leukemia]Richárd Kiss, Attila Péter Király, Júlia Gaál-Weisinger, et al.Orvosi Hetilap|August 9, 2021
Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019Júlia Weisinger, Ilona Tárkányi, Eid Hanna, et al.Virchows Archiv : an International Journal of Pathology|June 3, 2018
Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 proteinAmbrus Gángó, Bence Bátai, Martin Varga, et al.Pathology Oncology Research : POR|March 31, 2017
Familial Acute Myeloid Leukemia and Myelodysplasia in HungaryAttila Péter Király, Krisztián Kállay, Ambrus Gángó, et al.Pathology|August 1, 2021
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclaxAmbrus Gángó, Richárd Kiss, Péter Farkas, et al.The Journal of Molecular Diagnostics : JMD|August 11, 2018
High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple MyelomaSzabolcs Kosztolányi, Richárd Kiss, Lilit Atanesyan, et al.Pathology|January 5, 2019
Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasmsRéka Mózes, Ambrus Gángó, Adrienn Sulák, et al.Pageof 2